AMGN vs EPAC · P/E 24, rev $10.05B vs P/E 24, rev $616.9M
Amgen Inc (AMGN) versus Enerpac Tool Group Corp (EPAC) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Enerpac Tool Group Corp (EPAC) is a specialty industrial machinery company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported EPAC revenue for 2025-08-31 was $616.9M. Net income was $92.7M. EPAC currently screens at market cap $2.06B and trailing P/E 23.7.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. EPAC currently screens at market cap $2.06B and trailing P/E 23.7.
Not investment advice. Open the AMGN and EPAC stock pages for the full models.
Not investment advice.